These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 11967720)

  • 1. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of angiotensin II on pulse wave velocity in healthy humans.
    Rehman A; Rahman AR; Rasool AH; Naing NN
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):423-30. PubMed ID: 11680667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
    Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
    Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects.
    Latif F; Tandon S; Obeleniene R; Hankins SR; Berlowitz MS; Ennezat PV; Le Jemtel TH
    J Card Fail; 2001 Sep; 7(3):265-8. PubMed ID: 11561228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of angiotensin II on inflammation mediators in healthy subjects].
    Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):630-4. PubMed ID: 9205777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
    Tran D; Phoon S; Howes L
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):199-203. PubMed ID: 11881123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of nicotine on arterial stiffness and wave reflection in healthy young non-smokers.
    Adamopoulos D; Argacha JF; Gujic M; Preumont N; Degaute JP; van de Borne P
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):784-9. PubMed ID: 19207722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males.
    Nürnberger J; Dammer S; Opazo Saez A; Philipp T; Schäfers RF
    J Hum Hypertens; 2003 Mar; 17(3):153-8. PubMed ID: 12624604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Associations and related factors between pulse wave velocity and arterial system and augmentation index measured on different sites in a healthy population].
    Zhang MH; Ye P; Luo LM; Xiao WK; Wu HM; Liu DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):998-1005. PubMed ID: 21215229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR
    Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.